Author

D. Angiolillo

h-index 108 View on Semantic Scholar

We have 2 of 1,081 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention.

In patients with baseline anemia, 1-month DAPT was associated with lower major bleeding without an apparent ischemic trade-off, and among HBR patients undergoing PCI, abbreviated DAPT was associated with comparable ischemic outcomes regardless of anemia status.

F. D. di Muro, S. Sartori, D. Angiolillo et al. · European Journal of Preventi... · 0 citations

Aug 2026

De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.

DesC-HBR is the first randomized trial directly comparing multiple P2Y12 inhibitor de-escalation strategies in HBR patients post-ACS and will provide information to guide individualized antiplatelet strategies balancing ischemic protection and bleeding mitigation in HBR patients.

Francesco Costa, G. Vizzari, S. Zecchino et al. · Cardiovascular Revasculariza... · 0 citations